1
Views
2
CrossRef citations to date
0
Altmetric
Gene Expression

Ouabain-Resistant Mutants of the Rat Na,K-ATPase α2 Isoform Identified by Using an Episomal Expression Vector

, , , &
Pages 1367-1372 | Received 11 Oct 1989, Accepted 18 Dec 1989, Published online: 31 Mar 2023
 

Abstract

Site-directed mutagenesis was used to identify residues responsible for the >1,000-fold difference in ouabain sensitivity between the rat Na,K-ATPase α1 and α2 isoforms. A series of mutagenized cDNAs was constructed that replaced residues of the rat α2 subunit with the corresponding residues from the rat α1 subunit. These cDNAs were cloned into a mammalian episomal expression vector (EBOpLPP) and expressed in ouabainsensitive primate cells. Either of two single substitutions introduced into the rat α2 subunit cDNA (Leu111→Arg or Asn-122→Asp) conferred partial resistance (~10 μΜ ouabain) upon transformed cells. This resistance was intermediate between the levels conferred by the rat α1 cDNA (~500 μΜ ouabain) and the rat α2 cDNA (~0.2 μΜ ouabain). A double substitution of the rat α2 cDNA (Leu-111→Arg and Asn-122→Asp) conferred a resistance level equivalent to that obtained with rat al. These results demonstrate that the residues responsible for isoform-specific differences in ouabain sensitivity are located at the ends of the H1-H2 extracellular domain. The combination of site-directed mutagenesis and episomal expression provides a useful system for the selection and analysis of mutants.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.